A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care.
暂无分享,去创建一个
[1] N. Mays,et al. Assessing quality in qualitative research , 2000, BMJ : British Medical Journal.
[2] R. Gillon. Philosophical medical ethics , 1985 .
[3] R Jones,et al. A study of general practitioners' reasons for changing their prescribing behaviour , 1996, BMJ.
[4] M. Tilyard,et al. A qualitative comparative investigation of variation in general practitioners' prescribing patterns. , 2002, The British journal of general practice : the journal of the Royal College of General Practitioners.
[5] C. Bradley,et al. Factors which influence the decision whether or not to prescribe: the dilemma facing general practitioners. , 1992, The British journal of general practice : the journal of the Royal College of General Practitioners.
[6] J. Simpson,et al. Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care , 2003, BMJ : British Medical Journal.
[7] W. Hollingworth,et al. Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population , 1996, BMJ.
[8] C. Schechter,et al. Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease. , 1998, The American journal of cardiology.
[9] N. Campbell,et al. Secondary prevention clinics for coronary heart disease: randomised trial of effect on health , 1998, BMJ.
[10] J. Gillies,et al. Practical reasoning and decision making--Hippocrates' problem, Aristotle's answer. , 2002, The British journal of general practice : the journal of the Royal College of General Practitioners.
[11] W. Rogers. Are guidelines ethical? Some considerations for general practice. , 2002, The British journal of general practice : the journal of the Royal College of General Practitioners.
[12] C. Harries,et al. General practitioners' tacit and stated policies in the prescription of lipid lowering agents. , 1995, The British journal of general practice : the journal of the Royal College of General Practitioners.
[13] T. Jørgensen,et al. Assessment of coronary risk in general practice in relation to the use of guidelines: a survey in Denmark. , 2001, Preventive medicine.
[14] Raanan Gillon,et al. Philosophical medical ethics , 1985 .
[15] L. Corr,et al. Time trend analysis and variations in prescribing lipid lowering drugs in general practice , 1998, BMJ.
[16] N. Poulter,et al. Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey , 2000, BMJ : British Medical Journal.
[17] Sue Ziebland,et al. Analysing qualitative data , 2000, BMJ : British Medical Journal.
[18] C Langley,et al. Use of guidelines in primary care--practitioners' perspectives. , 1998, Family practice.
[19] G. Huby,et al. From trial data to practical knowledge: qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolaemia , 1998, BMJ.
[20] L. Toop,et al. Preventing cardiovascular disease in primary care , 2001, BMJ : British Medical Journal.